Literature DB >> 36260202

FDA Guidance on Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments: Old Wine in a New Bottle?

Ari Gnanasakthy1, Shanshan Qin2, Lindsey Norcross2.   

Abstract

Entities:  

Year:  2022        PMID： 36260202     DOI： 10.1007/s40271-022-00607-6

Source DB:  PubMed          Journal:  Patient        ISSN： 1178-1653            Impact factor:   3.481


× No keyword cloud information.
  3 in total

1.  Recent US Food and Drug Administration Efforts to Integrate the Patient's Perspective in Drug Development and Decision Making.

Authors:  Theresa Mullin; Pujita Vaidya; Meghana Chalasani
Journal:  Clin Pharmacol Ther       Date:  2019-01-04       Impact factor: 6.875

2.  Patient-Focused Drug Development: A New Direction for Collaboration.

Authors:  Eleanor M Perfetto; Laurie Burke; Elisabeth M Oehrlein; Robert S Epstein
Journal:  Med Care       Date:  2015-01       Impact factor: 2.983

3.  Time to See the Difference: Video Capture for Patient-Centered Clinical Trials.

Authors:  Elin Haf Davies; Clare Matthews; Adeline Merlet; Martine Zimmermann
Journal:  Patient       Date:  2022-01-07       Impact factor: 3.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.